Meeting Banner
Abstract #1330

DCE-MRI in Patients with MRCC: Pilot Study Investigating Possible Biomarkers of Antiangiogenic Therapy

Andrew B. Gill1, Gayathri D S Anandappa2, Andrew N. Priest1, Andrew J. Patterson1, Martin J. Graves1, Ilse Joubert1, Louise M. Cookson3, Kate M. Fife2, Philip S. Murphy3, Duncan B. Richards3, Evis Sala1, Tim Eisen2, Duncan I. Jodrell2, David J. Lomas1

1Radiology, Addenbrooke's Hospital & University of Cambridge, Cambridge, United Kingdom; 2Oncology, Addenbrooke's Hospital & University of Cambridge; 3GlaxoSmithKline, United Kingdom

This study investigated DCE-MRI indices as early indicators of the activity of the antiangiogenic drug bevacizumab when used in patients with metastatic renal cell carcinoma. Two base-line and two post-treatment examinations were performed on six patients. DCE-MRI data was analysed using an extended Tofts kinetic model with a model AIF to produce parameter maps which were then analysed to yield tumour medians. Significant reductions, compared to the mean of the base-line levels, were found in Ktrans and vp in tumours 3 days after treatment. IAUGC90 values showed a significant decrease both 4 hours after treatment and 3 days after treatment.

Abstract PDF Poster PDF

Keywords

achieved activity administered aligned approval approximately asset attempt averaging basis biomedical black blood blue cancer carcinoma carried categories central charitable chem collected committee consent consistent converged convergence conversion correlate curve custom days distributed drawn dynamic early either else employed employing enhancing ensured entered equations ethics exam examination examinations extent extracted fast final fitted fitting flow frame fritz generated gill giving gradient grant graves hospital hours hypo hypothesis identical included indicated indicates indicating indicators individual infusion initial input investigating investigation involving kinetic kingdom latter linear local made maps martin mass matrix median metastatic minutes model mutual operator outcome outlines paired part patient patients perfused perfusion pixel plots post process progresses proven radiology read received recruited reduction reductions renal repeated represented resolution sample satisfactorily scanner scheduled series sets significance skilled slice slices software specified spoiled subjected table tables temporal therapy third threshold treatment trial underwent upon uptake visit visits week written yield zero